1. Home
  2. VSTM vs ADSE Comparison

VSTM vs ADSE Comparison

Compare VSTM & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • ADSE
  • Stock Information
  • Founded
  • VSTM 2010
  • ADSE 1980
  • Country
  • VSTM United States
  • ADSE Ireland
  • Employees
  • VSTM N/A
  • ADSE N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • ADSE Industrial Specialties
  • Sector
  • VSTM Health Care
  • ADSE Consumer Discretionary
  • Exchange
  • VSTM Nasdaq
  • ADSE Nasdaq
  • Market Cap
  • VSTM 581.6M
  • ADSE 577.8M
  • IPO Year
  • VSTM 2012
  • ADSE N/A
  • Fundamental
  • Price
  • VSTM $10.71
  • ADSE $12.17
  • Analyst Decision
  • VSTM Strong Buy
  • ADSE
  • Analyst Count
  • VSTM 9
  • ADSE 0
  • Target Price
  • VSTM $13.38
  • ADSE N/A
  • AVG Volume (30 Days)
  • VSTM 2.8M
  • ADSE 48.0K
  • Earning Date
  • VSTM 11-04-2025
  • ADSE 12-23-2025
  • Dividend Yield
  • VSTM N/A
  • ADSE N/A
  • EPS Growth
  • VSTM N/A
  • ADSE N/A
  • EPS
  • VSTM N/A
  • ADSE N/A
  • Revenue
  • VSTM $13,379,000.00
  • ADSE $53,275,396.00
  • Revenue This Year
  • VSTM $88.60
  • ADSE $219.58
  • Revenue Next Year
  • VSTM $416.99
  • ADSE N/A
  • P/E Ratio
  • VSTM N/A
  • ADSE N/A
  • Revenue Growth
  • VSTM 33.79
  • ADSE N/A
  • 52 Week Low
  • VSTM $3.46
  • ADSE $7.89
  • 52 Week High
  • VSTM $11.25
  • ADSE $16.35
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 65.97
  • ADSE 66.96
  • Support Level
  • VSTM $7.29
  • ADSE $9.76
  • Resistance Level
  • VSTM $10.45
  • ADSE $10.68
  • Average True Range (ATR)
  • VSTM 0.68
  • ADSE 0.60
  • MACD
  • VSTM 0.23
  • ADSE 0.20
  • Stochastic Oscillator
  • VSTM 93.53
  • ADSE 91.98

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About ADSE ADS-TEC ENERGY PLC

ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: